Hogan Lovells Successfully Represents LabCorp in Victory Against Federal Trade Commission
28 February 2011
WASHINGTON, D.C., 28 February 2011 – Hogan Lovells US LLP announced today that the U.S. District Court for the Central District of California recently denied a Federal Trade Commission (FTC) bid to temporarily block Hogan Lovells client, Laboratory Corporation of America (LabCorp), in a $57.5 million deal for rival Westcliff Medical Laboratories Inc.
In early December 2010, the FTC sued to block the acquisition, alleging that LabCorp's acquisition of a medical lab in California violated antitrust laws. The Honorable Andrew J. Guilford denied the FTC's request for a preliminary injunction and also dissolved the temporary restraining order that had been in place since mid-December. He ruled that the FTC had not shown it was likely to succeed on the merits of its case during its administrative proceedings evaluating the merger. The FTC's hearing against the merger is scheduled to begin 2 May 2011.
The Hogan Lovells team representing LapCorp is led by partner and former FTC Chief Trial Council Robby Robertson and partner Corey Roush in the Washington, D.C. office, with assistance from associates Ben Holt, Leigh Oliver, Justin Bernick, Meghan Edwards-Ford, and Will Rawson.